Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI.

Tytuł:
The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI.
Autorzy:
Meng T; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
He N; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
He H; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
Liu K; Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Ke L; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
Liu H; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
Zhong L; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
Huang C; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
Yang A; Department of Breast Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
Zhou C; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China.
Qian L; Center for MRI Research, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.
Xie C; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, China. .
Źródło:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2020 Dec 14; Vol. 20 (1), pp. 88. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: <2014- > : London : Springer Nature
Original Publication: London : e-med, c2000]-
MeSH Terms:
Breast/*diagnostic imaging
Breast Neoplasms/*diagnostic imaging
Image Interpretation, Computer-Assisted/*methods
Magnetic Resonance Imaging/*methods
Adult ; Aged ; Area Under Curve ; Contrast Media ; Diagnosis, Differential ; Female ; Fibrocystic Breast Disease/diagnostic imaging ; Humans ; Middle Aged ; Prospective Studies ; ROC Curve ; Regression Analysis ; Sensitivity and Specificity
References:
J Int Med Res. 2018 May;46(5):1928-1935. (PMID: 29557239)
Radiology. 2004 Aug;232(2):585-91. (PMID: 15205478)
J Magn Reson Imaging. 2020 Mar;51(3):675-692. (PMID: 31264748)
MAGMA. 2016 Oct;29(5):777-88. (PMID: 27160300)
Eur Radiol. 2015 May;25(5):1392-8. (PMID: 25523455)
Magn Reson Med. 2016 Apr;75(4):1565-73. (PMID: 26014575)
AJR Am J Roentgenol. 2013 Feb;200(2):304-10. (PMID: 23345350)
Med Sci Monit. 2015 Feb 01;21:376-82. (PMID: 25640082)
Invest Radiol. 2017 Oct;52(10):647-657. (PMID: 28257339)
Korean J Radiol. 2017 Jan-Feb;18(1):238-248. (PMID: 28096732)
Magn Reson Imaging. 2019 Sep;61:66-72. (PMID: 31128225)
Br J Radiol. 2018 Sep 21;:20180479. (PMID: 30215550)
Radiology. 2019 Jan;290(1):33-40. (PMID: 30375925)
Br J Radiol. 2017 Jan;90(1069):20160715. (PMID: 27805423)
Acta Radiol Open. 2016 Feb 15;5(2):2058460115626757. (PMID: 26962461)
CA Cancer J Clin. 2019 Jan;69(1):7-34. (PMID: 30620402)
Eur Radiol. 2014 Nov;24(11):2848-56. (PMID: 25097131)
Ann Oncol. 2013 Nov;24(11):2786-93. (PMID: 23970015)
Radiology. 2017 Nov;285(2):546-554. (PMID: 28653860)
Magn Reson Imaging. 2008 Jan;26(1):26-34. (PMID: 17573224)
Radiol Clin North Am. 2014 May;52(3):481-7. (PMID: 24792650)
Clin Cancer Res. 2010 Jan 1;16(1):212-25. (PMID: 20008843)
Br J Radiol. 2017 Feb;90(1070):20160542. (PMID: 27925480)
Medicine (Baltimore). 2018 Jun;97(26):e11109. (PMID: 29952951)
Isr Med Assoc J. 2014 Feb;16(2):101-5. (PMID: 24645229)
Korean J Radiol. 2017 Jan-Feb;18(1):113-131. (PMID: 28096723)
AJNR Am J Neuroradiol. 2017 Jun;38(6):1103-1110. (PMID: 28450439)
Eur J Radiol. 1987 Aug;7(3):175-82. (PMID: 3653109)
Magn Reson Med. 1999 Mar;41(3):479-85. (PMID: 10204870)
J Magn Reson Imaging. 2020 Apr;51(4):993-1007. (PMID: 31347226)
J Appl Toxicol. 2014 Sep;34(9):1051-9. (PMID: 24652746)
Korean J Radiol. 2018 Mar-Apr;19(2):311-319. (PMID: 29520189)
Magn Reson Imaging Clin N Am. 2015 Feb;23(1):25-34. (PMID: 25476671)
Grant Information:
2017YFC0112605 National Key Research and Development Program of China; 20180005 Medical Science Research Foundation of Guangdong Province of China
Contributed Indexing:
Keywords: Breast cancer; Synthetic MRI; T1 mapping; T2 mapping
Substance Nomenclature:
0 (Contrast Media)
Entry Date(s):
Date Created: 20201215 Date Completed: 20210324 Latest Revision: 20210324
Update Code:
20240104
PubMed Central ID:
PMC7737277
DOI:
10.1186/s40644-020-00365-4
PMID:
33317609
Czasopismo naukowe
Background: Previous studies have indicated that quantitative MRI (qMR) is beneficial for diagnosis of breast cancer. As a novel qMR technology, synthetic MRI (syMRI) may be advantageous by offering simultaneous generation of T1 and T2 mapping in one scan within a few minutes and without concern to the deposition of the gadolinium contrast agent in cell nucleus. In this study, the potential of quantitative mapping derived from Synthetic MRI (SyMRI) to diagnose breast cancer was investigated.
Methods: From April 2018 to May 2019, a total of 87 patients with suspicious breast lesions underwent both conventional and SyMRI before treatment. The quantitative metrics derived from SyMRI, including T1 and T2 values, were measured in breast lesions. The diagnostic performance of SyMRI was evaluated with unpaired Student's t-tests, receiver operating characteristic curve analysis and multivariate logistic regression analysis. The AUCs of quantitative values were compared using Delong test.
Results: Among 77 patients who met the inclusion criteria, 48 were diagnosed with histopathological confirmed breast cancers, and the rest had benign lesions. The breast cancers showed significantly higher T1 (1611.61 ± 215.88 ms) values and lower T2 (80.93 ± 7.51 ms) values than benign lesions. The area under the ROC curve (AUC) values were 0.931 (95% CI: 0.874-0.989) and 0.883 (95% CI: 0.810-0.956) for T1 and T2 maps, respectively, in diagnostic discrimination between breast cancers and benign lesions. A slightly increased AUC of 0.978 (95% CI: 0.915-0.993) was achieved by combining those two relaxation-based quantitative metrics.
Conclusion: In conclusion, our preliminary study showed that the quantitative T1 and T2 values obtained by SyMRI could distinguish effectively between benign and malignant breast lesions, and T1 relaxation time showed the highest diagnostic efficiency. Furthermore, combining the two quantitative relaxation metrics further improved their diagnostic performance.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies